Lexeo Therapeutics

The Lexeo team traded the lab coats for tennis rackets and pickeball paddles at our Summer Event this year! A great afternoon of friendly competition, team building, and a reminder that the best teams are built both inside and outside the office. #TeamLexeo #Biotech #OneTeam

This past weekend, we recognized #ResearchAppreciationDay. At Lexeo, we’re grateful for the scientists, clinicians, research teams, and study participants whose dedication drives progress in genetic medicine. Thank you to everyone working to turn bold ideas into meaningful advances for patients. Learn more about our research in cardiovascular genetic diseases: https://lnkd.in/eFbqFviF #ResearchAppreciationDay #ScienceMatters #GeneticMedicine

Happy Independence Day weekend from all of us at Lexeo Therapeutics! As we head into the holiday, we’re reflecting on the values of freedom, possibility, and progress. These ideals continue to inspire bold thinking in how we advance science. Wishing everyone a safe and meaningful Fourth of July. #IndependenceDay #FourthofJuly #TeamLexeo

Earlier this month, Lexeo was grateful to welcome Jacob Thompson, speaker, author, and aspiring Paralympian, to speak at our Town Hall. Jacob’s dreams of becoming a professional athlete took a different turn when he was diagnosed with Friedreich ataxia (FA) in his early 20s, but he has never let FA hold him back. Today, Jacob is a fierce advocate for the rare disease community and continues to pursue his athletic dreams. Jacob’s story and determination to live life on his own terms was deeply moving and reinforced our purpose: to fundamentally change how genetic diseases are treated. Thank you, Jacob, for inspiring the Lexeo team! #FriedreichAtaxia #RareDisease #Inspiration #TeamLexeo

Cardiomyopathy Awareness Month is a reminder that heart disease doesn’t always look the way you’d expect. In Friedreich ataxia (FA), cardiomyopathy can begin silently, but it is a leading cause of mortality in individuals with FA. FA-CM can lead to abnormal heart rhythms, heart failure, and shortened lifespan. Awareness isn’t just about understanding a condition – it’s about knowing when to act. This month, we’re encouraging everyone with FA to connect with their cardiologist to learn more about the signs of FA-CM and take the next step toward care. #CardiomyopathyAwareness #FriedreichAtaxia #FACM #HeartDisease #GeneTherapy #RareDisease

Spending time with the FA community is one of the most meaningful parts of our work. Last month, we were grateful to connect with families affected by FA and to hear the powerful stories of David Van Och's family and Marc Likins' family. With multiple individuals in their families living with FA, their resilience, advocacy, and commitment to the community continue to inspire us every day. We’re thankful to them for sharing their experiences, to YouForTwo and FUJIFILM Biotechnologies for hosting, and to the broader community working together to advance research and drive progress toward new treatment options for FA. #RareDisease #GeneticMedicine #PatientCommunity #CardiacDisease 

Lexeo is excited to attend the 2026 BIO International Convention this week! Our CMO Narinder "Nani" Bhalla will be delivering a company presentation, and he’ll be joined in San Diego by CEO Nolan Townsend, COO José Manuel (Manny) Otero, and CFO Louis Tamayo to connect with leaders across biotech, pharma, and academia. We look forward to engaging with the global biotech community, as we continue our mission to fundamentally change how genetic diseases are treated. #BIO2026 #Biotech #GeneTherapy #Innovation #GeneticDisease

Happy Father’s Day to all the dads and father figures in our community! June is also Men’s Health Month – a reminder that heart disease remains the leading cause of death for men in the United States. Early detection and awareness can save lives. This month and beyond, we encourage everyone to prioritize their heart health. #FathersDay #MensHealthMonth #HeartHealth #CardiovascularDisease

Today, Lexeo joins people across the country in observing #Juneteenth, honoring the resilience and contributions of the Black community and reaffirming our commitment to fostering an inclusive culture grounded in respect, openness, and belonging.  #Juneteenth #Equity #Inclusion #OneTeam

June is Cardiomyopathy Awareness Month. Cardiomyopathy affects as many as 1 in 500 people and can lead to heart failure, dangerous heart rhythms, and sudden cardiac death. Lexeo is dedicated to developing treatments for rare genetic cardiomyopathies, including our clinical programs in Friedreich ataxia cardiomyopathy (FA-CM) and PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). This month and every month, we support the cardiomyopathy community and reaffirm our commitment to advancing genetic medicines that address the root causes of these diseases. Learn more: https://lnkd.in/eFbqFviF